Unveiling the Human Brain Virome in Brodmann Area 46: Novel Insights into Dysbiosis and its Association with Schizophrenia

Mahin Ghorbani
{"title":"Unveiling the Human Brain Virome in Brodmann Area 46: Novel Insights into Dysbiosis and its Association with Schizophrenia","authors":"Mahin Ghorbani","doi":"10.1093/schizbullopen/sgad029","DOIUrl":null,"url":null,"abstract":"Abstract Research suggests a potential role of the oral-neuro and gut-brain axes in schizophrenia, involving non-brain microbiomes such as salivary and gut microbiomes. However, the blood-brain barrier effectively prevents microorganism entry. Additionally, despite approximately 8% of the human genome consisting of retroviruses and the established link between viral infections and schizophrenia, the presence of a resident virome (a viral component of the microbiome) in the brain and its association with mental disorders remain unexplored. Methods: Whole-genome sequencing raw data from postmortem Brodmann Area 46 (BA46) tissue from 49 individuals (20 healthy controls [HCs], 29 with schizophrenia [SCZs]) obtained from the NCBI SRA database from BioProject: PRJNA422380.Virome profiles were retrieved using Metaphlan3, and viral signatures were identified using linear discriminant analysis effect size (LEfSe). Mann-Whitney tests and receiver operating characteristic curve validated the viral signatures. Results: In BA46, 30 distinct species representing 9 phyla, 10 classes, 10 orders, 13 families, and 19 genera were identified. HCs exhibited greater alpha diversity, and there were significant differences in beta diversity between the groups. LEfSe analysis highlighted distinct viral levels, including Escherichia virus Lambda, Escherichia virus phiV10, Human endogenous retrovirus K, Taterapox virus, Alcelaphine gammaherpesvirus 1, and Bovine gammaherpesvirus 4 in HCs, while Glypta fumiferanae ichnovirus and unknown virus showed higher levels in schizophrenia. Conclusion: This is the first study to identify a human brain virome associated with schizophrenia in BA46. Brain virome dysbiosis may be associated with mental illness, and viral signatures may serve as biomarkers for the early detection of schizophrenia.","PeriodicalId":21348,"journal":{"name":"Schizophrenia Bulletin Open","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schizophrenia Bulletin Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/schizbullopen/sgad029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Research suggests a potential role of the oral-neuro and gut-brain axes in schizophrenia, involving non-brain microbiomes such as salivary and gut microbiomes. However, the blood-brain barrier effectively prevents microorganism entry. Additionally, despite approximately 8% of the human genome consisting of retroviruses and the established link between viral infections and schizophrenia, the presence of a resident virome (a viral component of the microbiome) in the brain and its association with mental disorders remain unexplored. Methods: Whole-genome sequencing raw data from postmortem Brodmann Area 46 (BA46) tissue from 49 individuals (20 healthy controls [HCs], 29 with schizophrenia [SCZs]) obtained from the NCBI SRA database from BioProject: PRJNA422380.Virome profiles were retrieved using Metaphlan3, and viral signatures were identified using linear discriminant analysis effect size (LEfSe). Mann-Whitney tests and receiver operating characteristic curve validated the viral signatures. Results: In BA46, 30 distinct species representing 9 phyla, 10 classes, 10 orders, 13 families, and 19 genera were identified. HCs exhibited greater alpha diversity, and there were significant differences in beta diversity between the groups. LEfSe analysis highlighted distinct viral levels, including Escherichia virus Lambda, Escherichia virus phiV10, Human endogenous retrovirus K, Taterapox virus, Alcelaphine gammaherpesvirus 1, and Bovine gammaherpesvirus 4 in HCs, while Glypta fumiferanae ichnovirus and unknown virus showed higher levels in schizophrenia. Conclusion: This is the first study to identify a human brain virome associated with schizophrenia in BA46. Brain virome dysbiosis may be associated with mental illness, and viral signatures may serve as biomarkers for the early detection of schizophrenia.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
揭示人脑病毒在Brodmann区46:新见解失调及其与精神分裂症的关系
研究表明,口腔-神经和肠-脑轴在精神分裂症中的潜在作用,涉及非脑微生物组,如唾液和肠道微生物组。然而,血脑屏障有效地阻止了微生物的进入。此外,尽管大约8%的人类基因组由逆转录病毒组成,并且病毒感染与精神分裂症之间已经建立了联系,但大脑中存在一种常驻病毒(微生物组的一种病毒成分)及其与精神障碍的关系仍未得到探索。方法:从来自BioProject: PRJNA422380的NCBI SRA数据库中获取49个人(20名健康对照[hc], 29名精神分裂症[SCZs])的死后Brodmann Area 46 (BA46)组织的全基因组测序原始数据。使用Metaphlan3检索病毒组图谱,使用线性判别分析效应大小(LEfSe)识别病毒特征。曼-惠特尼测试和接受者工作特征曲线验证了病毒特征。结果:BA46共鉴定出9门10纲10目13科19属30种。hcc表现出更大的α多样性,组间β多样性差异显著。LEfSe分析强调了不同的病毒水平,包括大肠杆菌病毒Lambda,大肠杆菌病毒phiV10,人内源性逆转录病毒K, Taterapox病毒,Alcelaphine γ - herpesvirus 1和牛γ - herpesvirus 4,而在精神分裂症中显示了更高的病毒水平。结论:这是首次在BA46中发现与精神分裂症相关的人脑病毒。脑病毒群失调可能与精神疾病有关,病毒特征可能作为精神分裂症早期检测的生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Kenya Psychosis-Risk Outcomes Study (KePROS): Development of an Accelerated Medicine Partnership Schizophrenia (AMP SCZ)-Aligned Project in Africa Schizophrenia spectrum disorders (SSD): an empirical benchmark study of real-world diagnostic accuracy and reliability among leading international psychiatrists Predictors of Long-Acting Injectable Antipsychotic Medication Use in Patients with Schizophrenia Spectrum, Bipolar, and Other Psychotic Disorders in a United States Community-based, Integrated Health System Childhood Anxiety Symptoms as a Predictor of Psychotic Experiences in Adolescence in a High-Risk Cohort for Psychiatric Disorders Add-on Sodium Benzoate and N-Acetylcysteine in patients with early schizophrenia spectrum disorder: a multicentre, double-blind, randomised placebo controlled feasibility trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1